Urban Novak - Department of Medical Oncology Inselspital, Bern University Hospital

基本信息

Career Trajectory

Bio

Head Physician, Head of the Outpatient Clinic, Medical Oncology, University Cancer Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland Group Leader at the Department for BioMedical Research (DBMR), University of Bern Past President of the Project Group Lymphoma of the Swiss Group for Clinical Cancer Research (SAKK), Member of the SAKK Board

Research Interests

Papers共 216 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

161Tb Radioimmunotherapy As a Treatment for CD30-Positive Lymphomas

Elisa Rioja-Blanco,Yara Banz,Christoph Schlapbach,Urban Novak, Tanja Chiorazzo, Nicole L Bertschi,Peter Bernhardt, Pascal V Grundler,Nicholas P van der Meulen, Michal Grzmil,Roger Schibli, Martin Behe

Journal of nuclear medicine official publication, Society of Nuclear Medicineno. 6 (2025): 909-915

Cited0Views0WOSBibtex

Clonal Hematopoiesis in Diffuse Large B-Cell Lymphoma: Clinical and Molecular Correlations

Bloodno. Supplement 1 (2024): 1578-1578

Cited0Views0Bibtex

Lymphome Gastrique Malgre Eradication D'helicobacter Pylori - Un Cas Clinique

P. Lampropoulou, N. Marnas, M. -A. Ortner, J. Wolf,U. Novak, U. Schiemann

SWISS MEDICAL WEEKLY (2024): 34S-35S

Cited0Views0Bibtex

Severe ICANS after CAR T-cell Therapy and Assessment of Prevention with Levetiracetam for Seizure Prophylaxis Following CAR T-cell for DLBCL & PMBCL in Europe: a Survey on Behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT

Bone Marrow Transplantationno. 1 (2024): 100-102

Cited0Views0WOSNATUREBibtex

A Comprehensive Ddpcr Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications

Gertrud Wiedemann,Ulrike Bacher,Raphael Joncourt, Francoise Solly,Corinne C. Widmer,Sacha Zeerleder,Urban Novak,Thomas Pabst,Naomi A. Porret

International Journal of Molecular Sciencesno. 16 (2024): 8556-8556

Cited0Views0WOSBibtex

Assessing the Efficacy and Tolerability of PET-guided BrECADD Versus Ebeacopp in Advanced-Stage, Classical Hodgkin Lymphoma (HD21): a Randomised, Multicentre, Parallel, Open-Label, Phase 3 Trial

LANCETno. 10450 (2024): 341-352

Cited12Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn